Insmed Incorporated

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. 

CEO
William H. Lewis
CEOWilliam H. Lewis
Employees
1,664
Employees1,664
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
1988
Founded1988
Employees
1,664
Employees1,664

INSM Key Statistics

Market cap
23.65B
Market cap23.65B
Price-Earnings ratio
-19.00
Price-Earnings ratio-19.00
Dividend yield
Dividend yield
Average volume
5.71M
Average volume5.71M
High today
$114.51
High today$114.51
Low today
$108.22
Low today$108.22
Open price
$114.01
Open price$114.01
Volume
3.69M
Volume3.69M
52 Week high
$212.75
52 Week high$212.75
52 Week low
$64.85
52 Week low$64.85

Stock Snapshot

Insmed Incorporated(INSM) stock is priced at $109.00, giving the company a market capitalization of 23.65B. It carries a P/E multiple of -19.00.

As of 2026-05-17, Insmed Incorporated(INSM) stock has fluctuated between $108.22 and $114.51. The current price stands at $109.00, placing the stock +0.7% above today's low and -4.8% off the high.

Insmed Incorporated(INSM) shares are trading with a volume of 3.69M, against a daily average of 5.71M.

During the past year, Insmed Incorporated(INSM) stock moved between $64.85 at its lowest and $212.75 at its peak.

During the past year, Insmed Incorporated(INSM) stock moved between $64.85 at its lowest and $212.75 at its peak.

INSM News

Simply Wall St 20h
Insmed Shelf Registration Raises Questions On Funding Flexibility And Valuation

Insmed (NasdaqGS:INSM) has filed a shelf registration statement with the SEC, allowing it to issue various securities in the future. The filing is intended to...

Insmed Shelf Registration Raises Questions On Funding Flexibility And Valuation
TipRanks 2d
Insmed Shareholders Approve Directors, Executive Pay and Auditor

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Simply Wall St 4d
A Look At Insmed Valuation After Robust Q1 2026 Results And Reiterated Guidance

Insmed (INSM) has drawn fresh investor attention after reporting first quarter 2026 results that combined significant revenue contributions from BRINSUPRI and A...

A Look At Insmed Valuation After Robust Q1 2026 Results And Reiterated Guidance

Analyst ratings

100%

of 22 ratings
Buy
100%
Hold
0%
Sell
0%

More INSM News

TipRanks 4d
Insmed price target lowered to $185 from $205 at Truist

Truist lowered the firm’s price target on Insmed (INSM) to $185 from $205 and keeps a Buy rating on the shares. The firm updated its model following Q1 results,...

People also own

Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.